memantine has been researched along with naloxone in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Popik, P; Skolnick, P | 1 |
| Danysz, W; Popik, P | 1 |
| Bespalov, AY; Blokhina, EA; Sukhotina, IA | 1 |
| Chizh, BA; Englberger, W; Haase, G; Reissmüller, E; Scheede, M; Schlütz, H | 1 |
| Bisaga, A; Comer, SD; Fischman, MW; Kleber, HD; Popik, P; Ward, AS | 1 |
| Aguilar, MA; Cauli, O; Maldonado, C; Miñarro, J; Rodríguez-Arias, M | 1 |
| Bespalov, A; Danysz, W; Kashkin, V; Malyshkin, A; Neznanova, O; Sukhotina, I; Zakharova, E | 1 |
| Gewirtz, JC; Harris, AC; Rothwell, PE | 1 |
| Rachamalla, M; Rehni, AK; Singh, N; Tikoo, K | 1 |
| Etemad, L; Ghazanfari, S; Hosseinzadeh, H; Imenshahidi, M; Moshiri, M | 1 |
| DiGirolamo, G; Gonzalez, G; Kolodziej, M; Romero-Gonzalez, M; Smelson, D; Ziedonis, D | 1 |
| Steenbergen, PJ | 1 |
1 review(s) available for memantine and naloxone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for memantine and naloxone
| Article | Year |
|---|---|
The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
Topics: Adult; Dextromethorphan; Excitatory Amino Acid Antagonists; Female; Humans; Male; Memantine; Morphine; Naloxone; Opioid-Related Disorders; Receptors, N-Methyl-D-Aspartate; Substance Withdrawal Syndrome | 2001 |
Memantine improves buprenorphine/naloxone treatment for opioid dependent young adults.
Topics: Adolescent; Adult; Buprenorphine, Naloxone Drug Combination; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Memantine; Naloxone; Narcotic Antagonists; Opiate Substitution Treatment; Opioid-Related Disorders; Recurrence; Young Adult | 2015 |
11 other study(ies) available for memantine and naloxone
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence.
Topics: Amino Acids; Animals; Brain Chemistry; Dose-Response Relationship, Drug; Electrophysiology; Excitatory Amino Acid Antagonists; Glycine; Male; Memantine; Mice; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Receptors, N-Methyl-D-Aspartate | 1996 |
Inhibition of reinforcing effects of morphine and motivational aspects of naloxone-precipitated opioid withdrawal by N-methyl-D-aspartate receptor antagonist, memantine.
Topics: Animals; Feeding Behavior; Male; Maze Learning; Memantine; Memory; Morphine; Naloxone; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Reinforcement, Psychology; Space Perception; Substance Withdrawal Syndrome; Time Factors | 1997 |
Pretreatment with morphine potentiates naloxone-conditioned place aversion in mice: effects of NMDA receptor antagonists.
Topics: Animals; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Antagonists; Male; Memantine; Mice; Morphine; Naloxone; Narcotic Antagonists; Narcotics; Piperazines; Receptors, N-Methyl-D-Aspartate | 2000 |
Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil.
Topics: Analgesics; Animals; Decerebrate State; Dizocilpine Maleate; Electric Stimulation; Excitatory Amino Acid Antagonists; Male; Memantine; Motor Activity; N-Methylaspartate; Naloxone; Narcotic Antagonists; Pain; Piperidines; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Spinal Cord | 2001 |
Memantine presents different effects from MK-801 in motivational and physical signs of morphine withdrawal.
Topics: Animals; Behavior, Animal; Conditioning, Psychological; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Male; Memantine; Mice; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Substance Withdrawal Syndrome; Time Factors | 2003 |
The NMDA receptor channel blocker memantine and opioid receptor antagonist naltrexone inhibit the saccharin deprivation effect in rats.
Topics: Acamprosate; Animals; Choice Behavior; Ethanol; Male; Memantine; Naloxone; Naltrexone; Narcotic Antagonists; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Saccharin; Substance Withdrawal Syndrome; Sweetening Agents; Taurine | 2004 |
Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia.
Topics: Analgesics, Opioid; Animals; Hyperalgesia; Male; Memantine; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Substance Withdrawal Syndrome | 2008 |
Modulation of histone deacetylase attenuates naloxone-precipitated opioid withdrawal syndrome.
Topics: Analgesics, Opioid; Animals; Behavior, Animal; Brain; Cysteine Proteinase Inhibitors; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Hydroxamic Acids; Ileum; In Vitro Techniques; Male; Memantine; Mice; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Oligopeptides; Opioid-Related Disorders; Rats; Serpins; Substance Withdrawal Syndrome; Triglycerides; Viral Proteins | 2012 |
Effect of cyanocobalamin (vitamin B12) in the induction and expression of morphine tolerance and dependence in mice.
Topics: Analgesics, Opioid; Animals; Clonidine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Male; Memantine; Mice; Morphine; Morphine Dependence; Naloxone; Pain; Vitamin B 12 | 2014 |
Response of zebrafish larvae to mild electrical stimuli: A 96-well setup for behavioural screening.
Topics: Animals; Buprenorphine; Electric Stimulation; Electrodes; Equipment Design; Habituation, Psychophysiologic; Housing, Animal; Larva; Memantine; Models, Animal; Motor Activity; N-Methylaspartate; Naloxone; Narcotic Antagonists; Neurotransmitter Agents; Proof of Concept Study; Receptors, N-Methyl-D-Aspartate; Zebrafish | 2018 |